Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Clinres Farmacija is a European clinical trials and pharmacovigilance company. Its headquarters information indicates that it is based in Zagreb, Croatia, with an office in Sarajevo, Bosnia and Herzegovina. Based on the website content, it is not positioned as a standard SaaS platform or enterprise software product, but rather as a provider of professional outsourcing and compliance services across the full lifecycle of healthcare products.
Its services cover clinical development for new drugs and medical devices, as well as registration procedures for medicines, medical devices, food supplements, cosmetics, biocides, and general products. The main modules explicitly listed on the website include Clinical Trials, Regulatory Affairs, Pharmacovigilance, Quality Assurance, and Other services. The pharmacovigilance section emphasizes the ability to establish a robust pharmacovigilance system and also provides vigilance services for medical devices and other non-medicinal products.
The website does not disclose packages, subscription pricing, a free plan, trials, online purchasing, or payment methods. It also does not show typical SaaS-related information such as third-party integrations, APIs, developer documentation, permission management, workflow collaboration, self-hosting, or cloud deployment. Therefore, it should not be evaluated as a ready-to-buy software tool for direct deployment. It is more appropriate to contact the company for project-based or consulting-service quotations.
The official website includes a Data protection page and provides personal data protection notices in multiple regional languages, as well as an anti-bribery and anti-corruption statement. These are necessary trust signals for highly regulated areas such as clinical research, registration, and pharmacovigilance. However, the main site content does not list specific security certifications, audit standards, SLAs, or quality system certificates, so enterprise buyers should still conduct due diligence before procurement.
Its strengths are a relatively complete service chain covering multiple key compliance stages before and after clinical development, along with business touchpoints in Europe and the Balkan region. The drawbacks are the lack of digital product information and limited transparency around pricing, delivery models, and technical integration capabilities. It is better suited to pharmaceutical and healthcare companies that need support for European clinical trials, pharmacovigilance, medical device vigilance, and regulatory affairs, rather than teams looking for a general-purpose SaaS system.
Access from mainland China cannot be determined from the website content alone, and payment methods are not disclosed. If Chinese companies are considering cooperation, they should first confirm the covered service countries, contract currency, boundaries of compliance responsibility, and cross-border data arrangements via email or phone. If the requirement is for a software system, it would be better to separately evaluate specialized platforms for clinical trial management, pharmacovigilance, or regulatory affairs management.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on clinres-farmacija.hr official site.
clinres-farmacija.hr is an Croatia Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach clinres-farmacija.hr directly.